Vortosiran
Vortosiran (RBD4059) is a siRNA that inhibits the synthesis of coagulation factor XI (FXI). Vortosiran shows potent inhibitory activity against mouse FXI transcripts with an IC50 of 69 pM; it exerts similar effects on common FXI transcripts from humans and monkeys, with an IC50 of 59 pM. Vortosiran exhibits antithrombotic activity without impairing hemostatic function. Vortosiran can be used in research related to intravascular thrombosis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3061406-99-0
- Fòrmula: C463H620F7N154O291P39S6
- Peso molecular:14532.10
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:female C57BL/6J mice[2]
-
Dosage:1, 3 and 9 mg/kg
-
Administration:s.v.; single dose
-
Result:Prevented arterial and venous thrombosis, but tail bleeding did not prolong.
Chemical Information
-
No. CAS 3061406-99-0
-
Peso molecular 14532.10
-
Fòrmula C463H620F7N154O291P39S6
-
SMILES
[Vortosiran]
-
Synonyms
RBD4059
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
RNA interference technology
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing gene transcription or activating RNA degradation. This mechanism was discovered in plants in 1998 by Andrew Fire and Craig Mello. Today, this phenomenon can be observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)